Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 643, doi. 10.1038/sj.gt.3300843
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 1999 AND VI 6 AND IP 4
Results: 29
1
2
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 534, doi. 10.1038/sj.gt.3300840
- By:
- Publication type:
- Article
3
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 606, doi. 10.1038/sj.gt.3300841
- By:
- Publication type:
- Article
4
Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different molecules.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 694, doi. 10.1038/sj.gt.3300842
- By:
- Publication type:
- Article
5
Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 547
- By:
- Publication type:
- Article
6
Electropermeabilization of skeletal muscle enhances gene transfer in vivo.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 508, doi. 10.1038/sj.gt.3300847
- By:
- Publication type:
- Article
7
5-Azacytidine prevents transgene methylation in vivo.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 703, doi. 10.1038/sj.gt.3300848
- By:
- Publication type:
- Article
8
Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 471, doi. 10.1038/sj.gt.3300851
- By:
- Publication type:
- Article
9
Gene delivery to the myocardium by intrapericardial injection.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 683, doi. 10.1038/sj.gt.3300853
- By:
- Publication type:
- Article
10
Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 637, doi. 10.1038/sj.gt.3300854
- By:
- Publication type:
- Article
11
Murine MHC class II locus control region drives expression of human β-glucocerebrosidase in antigen presenting cells of transgenic mice.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 498, doi. 10.1038/sj.gt.3300855
- By:
- Publication type:
- Article
12
Efficient CFTR expression from AAV vectors packaged with promoters – the second generation.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 667, doi. 10.1038/sj.gt.3300856
- By:
- Publication type:
- Article
13
Enhancement of calcium phosphate-mediated transfection by inclusion of adenovirus in coprecipitates.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 676, doi. 10.1038/sj.gt.3300857
- By:
- Publication type:
- Article
14
Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 573, doi. 10.1038/sj.gt.3300858
- By:
- Publication type:
- Article
15
Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 629
- By:
- Publication type:
- Article
16
Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 515
- By:
- Publication type:
- Article
17
Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 564, doi. 10.1038/sj.gt.3300861
- By:
- Publication type:
- Article
18
Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 554, doi. 10.1038/sj.gt.3300862
- By:
- Publication type:
- Article
19
Lipoplex size is a major determinant of in vitro lipofection efficiency.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 651, doi. 10.1038/sj.gt.3300863
- By:
- Publication type:
- Article
20
Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 660, doi. 10.1038/sj.gt.3300864
- By:
- Publication type:
- Article
21
Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 585, doi. 10.1038/sj.gt.3300865
- By:
- Publication type:
- Article
22
RNA repair as a novel to genetic therapy.
- Published in:
- 1999
- By:
- Publication type:
- Editorial
23
Design of a muscle cell-specific expression vector utilising human vascular smooth muscle α-actin regulatory elements.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 616, doi. 10.1038/sj.gt.3300866
- By:
- Publication type:
- Article
24
Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 465, doi. 10.1038/sj.gt.3300870
- By:
- Publication type:
- Article
25
PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 595, doi. 10.1038/sj.gt.3300900
- By:
- Publication type:
- Article
26
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 482, doi. 10.1038/sj.gt.3300867
- By:
- Publication type:
- Article
27
In vivo targeted gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D-serine copolymer.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 689, doi. 10.1038/sj.gt.3300868
- By:
- Publication type:
- Article
28
Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 525, doi. 10.1038/sj.gt.3300869
- By:
- Publication type:
- Article
29
Politically correct gene therapy? A “clean environment” improves gene delivery to the brain!
- Published in:
- Gene Therapy, 1999, v. 6, n. 4, p. 463, doi. 10.1038/sj.gt.3300917
- By:
- Publication type:
- Article